Products marketed as "research grade" or sold direct to consumers without a clear prescriber relationship are a red flag
As you can see, significant, life-altering weight loss is possible across the board
Pramlintide is the first synthetic amylin analogue that approved for diabetes management with WL up to 7.9% [86]
While side effects are rare, some individuals may experience mild reactions, such as soreness at the injection site or temporary cold-like symptoms
Health Canada also notes people who shouldn't be using Ozempic include anyone who's had medullary thyroid cancer or has a family history of it, are allergic to Ozempic or any of the product's ingredients, or is pregnant or breastfeeding
For example, in a 48-week trial, retatrutide induced body weight reductions of ~24% in some groups